CalciMedica Inc. Company Profile
NASDAQ: CALCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CalciMedica at a glance
CalciMedica Inc. (NASDAQ: CALC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in La Jolla, CA. CalciMedica is led by Dr. A. Rachel Leheny Ph.D. and employs about 15 people. The company's shares have traded publicly since 2023.
At a market capitalization of $8.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001534133, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does CalciMedica do?
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
Business description based on the company's public filings.
Company information
- Legal name
- CalciMedica Inc.
- Ticker
- NASDAQ: CALC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. A. Rachel Leheny Ph.D.
- Employees
- 15
- Headquarters
- 505 Coast Boulevard South, La Jolla, CA, United States
- Phone
- 858 952 5500
- Website
- calcimedica.com
- IPO year
- 2023
- Market cap
- $8.69M
- SEC CIK
- 0001534133
- Latest annual report
- 10-K/A · Apr 30, 2026
Companies similar to CalciMedica
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OPTHOptimi Health Corp. | 1.51 | -13.71% | $8.65M | vs CALC |
| BIVIBioVie Inc. Class A | 0.80 | -12.07% | $8.58M | vs CALC |
| LEXXLexaria Bioscience Corp. | 4.03 | -10.24% | $8.49M | vs CALC |
| HINDVyome Holdings Inc. | 1.20 | -17.24% | $8.42M | vs CALC |
| GDTCCytoMed Therapeutics Limited | 0.755 | -2.33% | $9.01M | vs CALC |
| QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares | 1.29 | -9.15% | $8.29M | vs CALC |
| MBRXMoleculin Biotech Inc. | 7.74 | -2.40% | $8.22M | vs CALC |
| PTNPalatin Technologies Inc. | 4.58 | -7.10% | $8.16M | vs CALC |